Remove Documentation Remove Patient Care Remove Specialty Pharmacies
article thumbnail

Deucravacitinib Shows Joint, Skin Symptom Improvements in Psoriatic Arthritis

Drug Topics

POETYK PsA-1 is a randomized, double-blind, placebo-controlled phase 3 trial evaluating the efficacy and safety of deucravacitinib compared to placebo in adult patients with PsA who are naïve to biologic disease-modifying anti-rheumatic medications. of patients who received placebo. References 1.

article thumbnail

Q&A: Pharmacies Grapple With Patient Influx Amid Rite Aid Closures

Drug Topics

In Pennsylvania, the Fee-for-Service program has some mandates that the Medicaid Managed Care Organizations have to have clinical programs out there for medication management, diabetes education training, inhaler training and monitoring of blood pressure.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Breaking New Ground in Migraine Prevention: Eptinezumab-jjmr

Pharmacy Times

Pharmacists are essential in managing access, patient education, and monitoring outcomes, ensuring adherence and addressing administrative challenges. SHOW MORE Discover how Vyepti revolutionizes migraine prevention with rapid efficacy and strong safety, empowering pharmacists to enhance patient care.

article thumbnail

FDA Approves Sebetralstat for Hereditary Angioedema

Drug Topics

KONFIDENT was a randomized, double-blind, placebo-controlled, 3-way crossover phase 3 clinical trial that evaluated the efficacy and safety of sebetralstat for the treatment of hereditary angioedema attacks in adolescent and adult patients. Patients received either 300 mg or 600 mg sebetralstat or placebo. hours for 300 mg and 1.79

FDA 315
article thumbnail

Corticophobia Can Significantly Impact AD Management Strategies

Drug Topics

TCSs are the first-line anti-inflammatory treatment and their effectiveness and safety have been well documented.” However, regarding the strength, quantity, and duration of use recommended for these drugs, opinions vary among HCPs and patients. READ MORE: Dermatology Resource Center Pharmacy practice is always changing.

Vaccines 466
article thumbnail

CDC Report Finds No Connection Between Thimerosal and Autism

Drug Topics

The properties of thimerosal were documented to contribute to the safe use of multidose vials and packaging of vaccines, such as seasonal and pandemic influenza vaccines. 7 READ MORE: Immunizations Resource Center Ready to impress your pharmacy colleagues with the latest drug information, industry trends, and patient care tips?

Vaccines 387
article thumbnail

Obesity Medication Use Remains Low Among Children | ADA 2025

Drug Topics

image credit: syahrir / stock.adobe.com While data shows that obesity has been on the rise among children in recent history, the overall complications spurred on by childhood obesity have been well documented. Pharmacy practice is always changing. 1 “Guidelines recommend treating obesity with medications and lifestyle changes.”